Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
Open Access
- 1 February 2015
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 26, S22-S26
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
- Department of Health and Ageing, Australian Government
This publication has 31 references indexed in Scilit:
- Global epidemiology and genotype distribution of the hepatitis C virus infectionJournal of Hepatology, 2014
- Can hepatitis C virus infection be eradicated in people who inject drugs?Antiviral Research, 2014
- Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2013
- Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit AllClinical Infectious Diseases, 2013
- Treatment as prevention: The breaking of taboos is required in the fight against hepatitis C among people who inject drugsHepatology, 2013
- Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysisClinical Infectious Diseases, 2012
- Transmission of Hepatitis C Virus Among People Who Inject Drugs: Viral Stability and Association With Drug Preparation EquipmentThe Journal of Infectious Diseases, 2012
- Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriersJournal of Viral Hepatitis, 2012
- What Is Killing People with Hepatitis C Virus Infection?Seminars in Liver Disease, 2011
- Prevention of Hepatitis C Virus in Injecting Drug Users: A Narrow Window of OpportunityThe Journal of Infectious Diseases, 2011